Medtronic, Inc. (Medtronic) is a medical technology company. The Company provides products and therapies for use by medical professionals to meet the healthcare needs of their patients. Its primary products include those for cardiac rhythm disorders, cardiovascular disease, neurological disorders, spinal conditions and musculoskeletal trauma, urological and digestive disorders, and ear, nose, and throat and diabetes conditions. Medtronic operates through three segments that manufacture and sells device-based medical therapies. Its operating segments are Cardiac and Vascular Group, which consists of Cardiac Rhythm Disease Management (CRDM), Coronary, Structural Heart and Endovascular; Restorative Therapies Group, which consists of Spine, Neuromodulation and Surgical Technologies, and Diabetes Group. In January 2014, the Company acquired TYRX, Inc. In July 2014, it acquired Visualase, Inc. Effective August 27, 2014, the Company acquired the remaining 70% interest in NGC Medical SpA.